ABVX
Abivax SA · EURONEXT:ABVX
76.05 EUR−3.00 −3.80%
Abivax SA (EURONEXT:ABVX) last traded at 76.05 EUR, down 3.80% on the day. Over the past year the stock is down 16.34%. Its 52-week range is 60.45 to 139.00. It is in the Health Technology sector (Pharmaceuticals: Other).
Key statistics
Open78.00
Day range74.75 – 78.15
52-week range60.45 – 139.00
Volume121.30 K
Average volume (10 days)95.98 K
Market cap (USD)7.74 B
EPS (TTM) (USD)−5.98
Dividend yield0.00%
Beta (1 year)1.02
Revenue (TTM) (USD)0
Employees69
Performance
−3.61%1 week
−9.09%1 month
−29.78%3 months
−28.79%6 months
−35.22%Year to date
−16.34%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Abivax to Participate in Upcoming Fall Investor ConferencesEQS · 02 Nov 2026
- Abivax to Participate in Upcoming Fall Investor ConferencesGlobeNewswire · 02 Nov 2026
- Abivax Price Target Cut to $96.00/Share From $118.00 by WedbushDow Jones Newswires · 21 Oct 2026
- Abivax Price Target Maintained With a $175.00/Share by GuggenheimDow Jones Newswires · 20 Oct 2026
- Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPointSeeking Alpha · 15 Oct 2026
- Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3Seeking Alpha · 13 Oct 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026EQS · 30 Sep 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026GlobeNewswire · 30 Sep 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.